Dala Group LLC acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,075 shares of the biotechnology company’s stock, valued at approximately $1,313,000. Axon Enterprise accounts for approximately 1.1% of Dala Group LLC’s portfolio, making the stock its 22nd biggest position.
Several other hedge funds have also modified their holdings of the stock. Darwin Wealth Management LLC purchased a new stake in Axon Enterprise during the 2nd quarter worth about $37,000. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise in the 4th quarter valued at about $28,000. Sound Income Strategies LLC grew its position in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares in the last quarter. Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $30,000. Finally, AlphaCentric Advisors LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $34,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Axon Enterprise news, insider Elizabeth Reid Coughlin sold 1,554 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the sale, the insider owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the sale, the chief executive officer owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. This represents a 0.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 58,989 shares of company stock valued at $30,527,983 over the last three months. 4.20% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on AXON
Axon Enterprise Trading Up 0.5%
AXON opened at $527.76 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company has a market cap of $42.54 billion, a P/E ratio of 211.95, a PEG ratio of 10.77 and a beta of 1.38. The business’s 50-day simple moving average is $497.09 and its 200-day simple moving average is $476.61.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s revenue was up 33.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.47 earnings per share. As a group, equities research analysts expect that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
